Attovia grants CSO Petter Veiby 140,000 stock options
Attovia Therapeutics, Inc. reported that Chief Scientific Officer Petter Veiby received a grant of stock options covering 140,000 shares of common stock at an exercise price of $17.00 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. reported that Chief Scientific Officer Petter Veiby received a grant of stock options covering 140,000 shares of common stock at an exercise price of $17.00 per share. The options expire on August 3, 2036 and vest 25% on August 4, 2027, with the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued service. Following this award, Veiby holds options on 140,000 shares directly.
Insider Trade Summary
Grant/Award: 140,000 shares
Grant/Award
1 txn
Insider
Veiby Petter
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 140,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 140,000 contracts (Direct)
Footnotes (1)
- F1. 25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.
Key Figures
Options Granted: 140,000 shares
Exercise Price: $17.00 per share
Expiration Date: August 3, 2036
+3 more
6 metrics
Options Granted
140,000 shares
Stock Option (Right to Buy) grant to Chief Scientific Officer on 2026-08-04
Exercise Price
$17.00 per share
Conversion or exercise price of the stock options
Expiration Date
August 3, 2036
Expiration of the stock option award
Initial Vesting Tranche
25% on August 4, 2027
First vesting date for the option grant
Remaining Vesting Period
36 months
Remaining options vest in equal monthly installments after initial 25%
Post-Grant Holdings
140,000 options
Total options held by Petter Veiby following the reported grant
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 17.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-08-03"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"25% of the options shall vest on August 4, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Attovia Therapeutics (ATTO) disclose about Petter Veiby’s new stock options?
Attovia Therapeutics disclosed that Chief Scientific Officer Petter Veiby received a grant of 140,000 stock options. These options relate to common stock, have a $17.00 exercise price, and expire on August 3, 2036, forming part of his equity-based compensation.
What is the exercise price of Petter Veiby’s new Attovia (ATTO) stock options?
The exercise price of Petter Veiby’s new options is $17.00 per share. This means he can purchase up to 140,000 shares of Attovia common stock at $17.00, subject to the vesting schedule and his continued service to the company.
How do Petter Veiby’s Attovia (ATTO) stock options vest over time?
Veiby’s options vest 25% on August 4, 2027, with the remaining 75% vesting in equal monthly installments over the next 36 months. Vesting is expressly conditioned on his continued service to Attovia through the applicable vesting dates.
When do Petter Veiby’s newly granted Attovia (ATTO) options expire?
The newly granted options expire on August 3, 2036. After this expiration date, Veiby will no longer be able to exercise the 140,000 options, even if they have vested, so long-term value depends on exercising before that date.
How many Attovia (ATTO) options does Petter Veiby hold after this grant?
After this grant, Petter Veiby holds options covering 140,000 shares of Attovia common stock directly. This entire amount relates to the newly awarded stock option grant reported in the filing, reflecting his current option position from this award.
Is Petter Veiby’s Attovia (ATTO) option grant a market purchase or a compensation award?
The reported transaction is a grant/award acquisition of stock options, not a market purchase. It carries a transaction code for a grant, award, or other acquisition and an exercise price of $17.00, consistent with equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
